Kibow Biotech Inc.
Kibow Biotech specializes in researching, developing, and commercializing patented synbiotics (pre and probiotic) as dietary supplements. In our 24 years, Kibow has been widely recognized as a pioneer in modulating the gut microbiome to address organ-specific and diverse health conditions. Our key focus is on kidney health with Renadyl™, a clinically validated formulation that promotes healthy kidney function utilizing "Enteric Dialysis ®," also called "Intestinal Dialysis™." Kibow is most proud of the trust we have earned among renal patients, Nephrologists, and clinical professionals associated with renal health care internationally.
Kibow's mission is to provide convenient and efficacious kidney health products to CKD patients. Toward advancing this goal, Kibow recently obtained an IND through CBER/FDA to perform a large-scale multi-site RCT on CKD-IV patients (N=630) using the investigational product, US-APR2020, with the goal of arresting the decline of eGFR, potentially delaying the need for dialysis.